Gambit Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Gambit Capital Management's LLY Position: Q1 2026 in Review
Gambit Capital Management increased its Eli Lilly (LLY) stake by 5.8% in Q1 2026, buying an estimated $1.44M and bringing the position to 26,000 shares worth $23.9M. The position accounts for 16.47% of the portfolio, ranked #1.
Gambit Capital Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $26.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Gambit Capital Management held 26,000 shares of Eli Lilly worth $23.9M as of Q1 2026.
- Gambit Capital Management bought 1,424 Eli Lilly shares in Q1 2026, an estimated $1.44M.
- Eli Lilly made up 16.47% of Gambit Capital Management's portfolio in Q1 2026, its #1 holding.
- Gambit Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
- Gambit Capital Management's Eli Lilly position peaked at $26.5M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Gambit Capital Management's 13F filing for Q1 2026, filed 14 May 2026.